abrdn Focused U.S. Small Cap Active ETF
AFSC - ETF AI Analysis
Top Page
abrdn Focused U.S. Small Cap Active ETF (AFSC)
AFSC, the abrdn Focused U.S. Small Cap Active ETF, has a solid overall rating, reflecting a mix of strong small-cap financial and industrial names alongside some more challenged holdings. High-quality contributors like Wintrust Financial (WTFC) and Ameris Bancorp (ABCB) support the fund with strong financial performance, positive earnings calls, and supportive technical trends, while names such as Quaker Chemical (KWR) and Magnolia Oil & Gas (MGY) face profitability, valuation, or bearish technical pressures that modestly weigh on the fund’s appeal. The main risk is that several holdings show signs of high or uncertain valuations and some sector-specific headwinds, which can increase volatility for investors.
AFSC vs. SPDR S&P 500 ETF (SPY)
- AUM
- 16.50M
- Region
- North America
- Expense Ratio
- 0.65%
- Beta
- 0.80
- Issuer
- aberdeen
- Inception Date
- Feb 18, 2025
- Dividend Yield
- 0.07%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
AFSC Summary
AFSC is the abrdn Focused U.S. Small Cap Active ETF, which invests in a handpicked group of smaller U.S. companies instead of tracking a fixed index. It spreads money across areas like health care, financials, technology, and industrials, with holdings such as Brinker International and Merit Medical Systems. Investors might consider AFSC if they want growth potential from smaller, up‑and‑coming businesses and added diversification beyond large, well-known stocks. However, because it focuses on small companies and is actively managed, its price can be more volatile and can go up and down more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, with professionals selecting small-cap stocks rather than just tracking an index.
What would affect this ETF?
This ETF could benefit if the U.S. economy stays healthy, as small-cap companies in areas like health care, financials, and technology often grow faster when business activity, innovation, and consumer spending are strong, and its active managers can try to pick the most promising names. On the downside, small caps can be hit harder by economic slowdowns, rising interest rates that increase borrowing costs, or tighter financial regulations that affect regional banks and other financial holdings, and the fund’s focus on the U.S. market means it is heavily exposed to domestic economic and policy risks.
AFSC Top 10 Holdings
AFSC is leaning heavily into U.S. small-cap health care, with Kiniksa Pharmaceuticals and Ligand Pharma acting as key engines of recent gains, both riding strong momentum and upbeat fundamentals. Merit Medical Systems adds another steady health-care pillar, while Magnolia Oil & Gas gives the fund a cyclical energy kicker that’s been more mixed but still supportive. On the flip side, Supernus Pharmaceuticals is losing steam, and regional banks like Ameris Bancorp are lagging, creating a tug-of-war between high-growth medical names and more challenged financials—all firmly rooted in the U.S. market.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| American Healthcare REIT, Inc. | 3.86% | $362.53K | $13.56B | 19.10% | 64Neutral | |
| Merit Medical Systems | 3.34% | $314.13K | $5.15B | 2.09% | 68Neutral | |
| Q2 Holdings | 3.30% | $310.65K | $4.31B | 0.36% | 75Outperform | |
| Quaker Chemical | 3.14% | $295.66K | $2.66B | 22.09% | 58Neutral | |
| Supernus | 3.08% | $290.02K | $6.07B | -10.23% | 66Neutral | |
| Seacoast Banking Of Florida | 3.02% | $283.45K | $3.14B | 10.26% | 62Neutral | |
| Magnolia Oil & Gas | 2.97% | $279.35K | $6.19B | 2.42% | 65Neutral | |
| ONE Gas | 2.94% | $276.65K | $5.19B | 1.41% | 69Neutral | |
| Wintrust Financial | 2.88% | $270.30K | $10.12B | 19.78% | 78Outperform | |
| Ameris Bancorp | 2.85% | $268.22K | $5.47B | 13.84% | 78Outperform |
AFSC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AFSC, the sentiment is Negative. The current price of 36.01 is below the 20-day moving average (MA) of 36.38, below the 50-day MA of 36.65, and above the 200-day MA of 35.72, indicating a neutral trend. The MACD of -0.21 indicates Positive momentum. The RSI at 45.61 is Neutral, neither overbought nor oversold. The STOCH value of 25.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AFSC.
AFSC Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $36.01 | $39.00(8.30% Upside) | $16.50M | 0.65% | 65Neutral | |
| $35.80 | $51.07(42.67% Upside) | $82.28M | 0.64% | 64Neutral | |
| $26.12 | $34.05(30.38% Upside) | $79.75M | 0.75% | 65Neutral | |
| $28.28 | $37.23(31.64% Upside) | $60.35M | 0.61% | 66Neutral | |
| $27.83 | $38.17(37.13% Upside) | $32.35M | 0.49% | 66Neutral | |
| $19.30 | $24.51(27.00% Upside) | $25.11M | 0.86% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AFSC | abrdn Focused U.S. Small Cap Active ETF | 36.01 | 6.24 | 20.98% | |
| RUSC | US Small Cap Equity Active ETF | 35.80 | 6.17 | 20.84% | |
| AIMS | Acuitas Small Cap Active ETF | 26.12 | 0.94 | 3.73% | |
| SYZ | Lazard US Systematic Small Cap Equity ETF | 28.28 | 4.42 | 18.52% | |
| ESSC | Eventide Small Cap ETF | 27.83 | 3.17 | 12.87% | |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 19.30 | 2.63 | 15.80% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
